0001140361-24-010435.txt : 20240229 0001140361-24-010435.hdr.sgml : 20240229 20240229161632 ACCESSION NUMBER: 0001140361-24-010435 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 18 CONFORMED PERIOD OF REPORT: 20240229 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240229 DATE AS OF CHANGE: 20240229 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Quantum-Si Inc CENTRAL INDEX KEY: 0001816431 STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 851388175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39486 FILM NUMBER: 24703879 BUSINESS ADDRESS: STREET 1: 29 BUSINESS PARK DRIVE CITY: BRANFORD STATE: CT ZIP: 06405 BUSINESS PHONE: (203) 458-7100 MAIL ADDRESS: STREET 1: 29 BUSINESS PARK DRIVE CITY: BRANFORD STATE: CT ZIP: 06405 FORMER COMPANY: FORMER CONFORMED NAME: HighCape Capital Acquisition Corp. DATE OF NAME CHANGE: 20200629 8-K 1 ef20022499_8k.htm 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): February 29, 2024
 
QUANTUM-SI INCORPORATED
(Exact name of registrant as specified in its charter)

Delaware
001-39486
85-1388175
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

29 Business Park Drive
Branford, Connecticut
(Address of principal executive offices)
  
06405
(Zip Code)

Registrant’s telephone number, including area code: (866) 688-7374
 
N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
  
Trading Symbol(s)
  
Name of each exchange on
which registered
Class A common stock, par value $0.0001 per share
  
QSI
  
The Nasdaq Stock Market LLC
Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
  
QSIAW
  
The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company          ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
 
Item 2.02.
Results of Operations and Financial Condition.

On February 29, 2024, Quantum-Si Incorporated (the “Company”) issued a press release announcing its results for the fourth quarter and full year ended December 31, 2023 and providing a business update. A copy of the press release is furnished as Exhibit 99.1 hereto.

The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01
Financial Statements and Exhibits.

(d)
Exhibits.

Exhibit
No.
  
Description
 

 
Press Release dated February 29, 2024
 
Use of Non-GAAP Financial Measures
104
  
Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
QUANTUM-SI INCORPORATED
   
 
By:
/s/ Jeffry Keyes
 
Name:
Jeffry Keyes
 
Title:
Chief Financial Officer
     
Date: February 29, 2024
    
 

 EX-99.1 2 ef20022499_ex99-1.htm EXHIBIT 99.1
Exhibit 99.1

 
Quantum-Si Reports Fourth Quarter and Full Year 2023 Financial Results
Finalizing Commercial Readiness for Expected Full Commercial Launch by the End of Q1 2024
Releases Full Year 2024 Financial Guidance
 
BRANFORD, Conn. -- (BUSINESS WIRE) – Feb. 29, 2024 -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced financial results for the fourth quarter and full year ended December 31, 2023.

Press Release Highlights
●
Recorded revenue of $400,000 in the fourth quarter of 2023 as the Company continued its previously communicated controlled commercial launch of its Platinum® instrument
●
Finalizing commercial readiness for expected full commercial launch by the end of Q1 2024
●
Launched version 2 of its sequencing kit in early February 2024 and has begun shipping to customers
●
Announced the Company’s third international distribution partner, TOMY Digital Biology Co. Ltd., based in Japan
●
Announced the planned release of a version 3 of its sequencing kit by the end of Q3 2024
●
Provides full year 2024 financial guidance

“We made great progress in the fourth quarter of 2023 and are seeing the early results of that work now, including the launch of our version 2 sequencing kit in early February 2024, significant progress on scaling up our commercial resources, and the addition of our third distributor to our international network”, said Jeff Hawkins, President and Chief Executive Officer of Quantum-Si.  “We are pleased with our ability to launch the version 2 sequencing kit well within the previously provided timeline.  We are excited about the acceleration we are seeing in our R&D pipeline and believe we are in a strong position to deliver a steady cadence of product enhancements and new capabilities to the market in 2024 and beyond.  A version 3 of our sequencing kit is under development now and we expect to deliver it to the market by the end of Q3 2024.  We are also making solid progress across library prep and instrument development programs that we believe will fuel the future growth of the Company for years to come.”

Hawkins continued, “With all the progress that we have made over the last year, coupled with finalizing our commercialization readiness, I am pleased to announce that we expect to commence our full commercial launch of our Platinum® instrument by the end of Q1 2024.  We have also released full year 2024 financial guidance.”

Fourth Quarter 2023 and Full Year 2023 Financial Results
During the fourth quarter of 2023, the Company continued its controlled commercial launch of its Platinum instrument, recording revenue of $400,000.  Gross profit was $178,000 and gross margin was 45%. For the full year ended December 31, 2023, the Company recorded revenue of $1.1 million, gross profit of $488,000, and gross margin of 45%.  The periodic gross margin rate is expected to be variable in the near term as the Company works through the initial stages of commercialization as well as the timing and mix of product sales between instruments and consumable kits.

Total operating expenses were $28.1 million in the fourth quarter of 2023, compared to $38.8 million for the same period in the prior year, and $111.7 million for the full year ended December 31, 2023, compared to $123.8 million for the same period in the prior year. Adjusted total operating expenses were $26.3 million in the fourth quarter of 2023, compared to $25.3 million for the same period in the prior year, and adjusted total operating expenses for the full year ended December 31, 2023, were $98.9 million compared to $103.2 million for the same period in the prior year.  Overall adjusted operating expenses for 2023 compared to 2022 have decreased as the Company focused on deploying capital in an efficient manner to R&D projects while still building commercial capabilities.

Net loss was $22.0 million in the fourth quarter of 2023, compared to a net loss of $33.1 million in the same period of the prior year, and a net loss of $96.0 million for the full year ended December 31, 2023, compared to a net loss of $132.4 million for the same period in the prior year. Adjusted EBITDA was negative $25.1 million in the fourth quarter of 2023, compared to negative $24.5 million in the same period of the prior year, and negative $94.3 million for the full year ended December 31, 2023, compared to negative $100.6 million for the same period in the prior year.  A reconciliation of the non-GAAP financial measures, adjusted total operating expenses and adjusted EBITDA, is provided in a table included in this press release.

As of December 31, 2023, the Company’s cash and cash equivalents and investments in marketable securities were $257.7 million.

2024 Financial Guidance
For the full year 2024, the Company provided the following financial guidance:

Revenue
 $3.7 - $4.2 million
Adjusted total operating expenses
Less than $103 million
Total cash usage
 Less than $100 million

The Company also maintains the expectation that the balance in cash and cash equivalents and investments in marketable securities of $257.7 million as of December 31, 2023 will provide a runway into 2026.

Webcast and Conference Call Information
Quantum-Si will host a conference call to discuss its fourth quarter and full year 2023 financial results on Thursday, February 29, 2024, at 4:30 p.m. Eastern Time. Individuals interested in listening to the conference call may do so by joining the live webcast in the Investors section of the Quantum-Si website under Events & Presentations. Alternatively, individuals can register online to receive a dial-in number and personalized PIN to participate in the call. An archived webcast of the event will be available for replay following the event.

About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at quantum-si.com or follow us on LinkedIn or X.

Use of Non-GAAP Financial Measures
This press release presents the non-GAAP financial measures “adjusted total operating expenses” and “adjusted EBITDA.” The most directly comparable measures for these non-GAAP financial measures are total operating expenses and net loss. The Company has included below adjusted total operating expenses, which presents the Company’s total operating expenses after excluding goodwill impairment, stock-based compensation and restructuring costs.  In addition, adjusted EBITDA further excludes interest, taxes, depreciation, amortization, dividend income, unrealized and realized gains and losses on marketable securities, changes in fair value of warrant liabilities and other income or expense.

A discussion of the reasons why management believes that the presentation of non-GAAP financial measures provides useful information to investors regarding the Company’s financial condition and results of operations is included as Exhibit 99.2 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on February 29, 2024.

Forward Looking Statements
This press release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. The actual results of the Company may differ from its expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions (or the negative versions of such words or expressions) are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, the Company's expectations with respect to future performance and development and commercialization of products and services, its anticipated cash runway and its financial guidance for the full year 2024. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from those discussed in the forward-looking statements. Most of these factors are outside the Company's control and are difficult to predict. Factors that may cause such differences include, but are not limited to: the inability to maintain the listing of the Company's Class A common stock on The Nasdaq Stock Market; the ability of the Company to grow and manage growth profitably and retain its key employees; the Company’s ongoing leadership transitions; changes in applicable laws or regulations; the ability of the Company to raise financing in the future; the success, cost and timing of the Company's product development and commercialization activities; the commercialization and adoption of the Company’s existing products and the success of any product the Company may offer in the future; the potential attributes and benefits of the Company’s commercialized Platinum™ protein sequencing instrument and kits and the Company’s other products once commercialized; the Company's ability to obtain and maintain regulatory approval for its products, and any related restrictions and limitations of any approved product; the Company's ability to identify, in-license or acquire additional technology; the Company's ability to maintain its existing lease, license, manufacture and supply agreements; the Company's ability to compete with other companies currently marketing or engaged in the development or commercialization of products and services that serve customers engaged in proteomic analysis, many of which have greater financial and marketing resources than the Company; the size and growth potential of the markets for the Company's products and services, and its ability to serve those markets once commercialized, either alone or in partnership with others; the Company's estimates regarding future expenses, future revenue, capital requirements and needs for additional financing; the Company's financial performance; and other risks and uncertainties described under "Risk Factors" in the Company’s  most recent Annual Report on Form 10-K, and in the Company's other filings with the SEC. The Company cautions that the foregoing list of factors is not exclusive. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based.
QUANTUM-SI INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(in thousands, except per share amounts)
(Unaudited)


  
Three months ended December 31,
    
Years ended December 31,
  

 
2023
    
2022
    
2023
    
2022
  
Revenue
                        
Product
  
$
377
    
$
-
    
$
1,031
    
$
-
  
Service
    
23
      
-
      
51
      
-
  
Total revenue
    
400
      
-
      
1,082
      
-
  
 
                                
Cost of revenue
    
222
      
-
      
594
      
-
  

                               
Gross profit
    
178
      
-
      
488
      
-
  
Operating expenses:
                                
Research and development
    
16,437
      
18,157
      
67,025
      
72,062
  
Selling, general and administrative
    
11,624
      
11,203
      
44,634
      
42,296
  
Goodwill impairment
    
-
      
9,483
      
-
      
9,483
  
Total operating expenses
    
28,061
      
38,843
      
111,659
      
123,841
  
Loss from operations
    
(27,883
)
    
(38,843
)
    
(111,171
)
    
(123,841
)
Dividend income
    
2,262
      
2,013
      
9,536
      
5,301
  
Gain (loss) on marketable securities, net
    
3,774
      
2,180
      
5,587
      
(20,603
)
Change in fair value of warrant liabilities
    
(197
)
    
1,122
      
(278
)
    
6,243
  
Other (expense) income, net
    
(4
)
    
388
      
366
      
458
  
Loss before provision for income taxes
    
(22,048
)
    
(33,140
)
    
(95,960
)
    
(132,442
)
Provision for income taxes
    
-
      
-
      
-
      
-
  
Net loss and comprehensive loss
  
$
(22,048
)
  
$
(33,140
)
  
$
(95,960
)
  
$
(132,442
)

                               
Net loss per common share attributable to common stockholders, basic and diluted
  
$
(0.16
)
  
$
(0.24
)
  
$
(0.68
)
  
$
(0.95
)
Weighted-average shares used to compute net loss per share attributable
to common stockholders, basic and diluted
    
141,575
      
139,849
      
141,300
      
139,255
  

QUANTUM-SI INCORPORATED
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share and par value amounts)
(Unaudited)

   
December 31,
    
December 31,
  
   
2023
    
2022
  
Assets
            
Current assets:
            
Cash and cash equivalents
  
$
133,860
    
$
84,319
  
Marketable securities
    
123,876
      
266,990
  
Accounts receivable, net of allowance of $0 and $0, respectively
    
368
      
-
  
Inventory, net
    
3,945
      
-
  
Prepaid expenses and other current assets
    
4,261
      
6,873
  
Total current assets
    
266,310
      
358,182
  
Property and equipment, net
    
16,275
      
16,849
  
Internally developed software
    
532
      
-
  
Operating lease right-of-use assets
    
14,438
      
15,757
  
Other assets
    
695
      
697
  
Total assets
  
$
298,250
    
$
391,485
  
Liabilities and stockholders' equity
                
Current liabilities:
                
Accounts payable
  
$
1,766
    
$
3,903
  
Accrued expenses and other current liabilities
    
8,277
      
10,434
  
Current portion of operating lease liabilities
    
1,566
      
1,369
  
Total current liabilities
    
11,609
      
15,706
  
Warrant liabilities
    
1,274
      
996
  
Operating lease liabilities
    
13,737
      
16,077
  
Other long-term liabilities
    
11
      
-
  
Total liabilities
    
26,631
      
32,779
  

               
Stockholders' equity
                
Class A Common stock, $0.0001 par value; 600,000,000 shares authorized as of December 31, 2023 and
December 31, 2022; 121,832,417 and 120,006,757 shares issued and outstanding as of December 31, 2023 and
December 31, 2022, respectively.
    
12
      
12
  
Class B Common stock, $0.0001 par value; 27,000,000 shares authorized as of December 31, 2023 and
December 31, 2022; 19,937,500 shares issued and outstanding as of December 31, 2023 and December 31, 2022.
    
2
      
2
  
Additional paid-in capital
    
767,239
      
758,366
  
Accumulated deficit
    
(495,634
)
    
(399,674
)
Total stockholders' equity
    
271,619
      
358,706
  
Total liabilities and stockholders' equity
  
$
298,250
    
$
391,485
  
QUANTUM-SI INCORPORATED
RECONCILIATION OF U.S. GAAP TO NON-GAAP FINANCIAL MEASURES
(in thousands)
(Unaudited)

   
Three months ended December 31,
    
Years ended December 31,
  
   
2023
    
2022
    
2023
    
2022
  
Net loss
  
$
(22,048
)
  
$
(33,140
)
  
$
(95,960
)
  
$
(132,442
)
Adjustments to reconcile to EBITDA:
                                
Dividend income
    
(2,262
)
    
(2,013
)
    
(9,536
)
    
(5,301
)
Depreciation and amortization
    
1,093
      
795
      
4,156
      
2,584
  
EBITDA
    
(23,217
)
    
(34,358
)
    
(101,340
)
    
(135,159
)
Adjustments to reconcile to Adjusted EBITDA:
                                
Goodwill impairment
    
-
      
9,483
      
-
      
9,483
  
(Gain) loss on marketable securities, net
    
(3,774
)
    
(2,180
)
    
(5,587
)
    
20,603
  
Change in fair value of warrant liabilities
    
197
      
(1,122
)
    
278
      
(6,243
)
Other expense (income), net
    
4
      
(388
)
    
(366
)
    
(458
)
Stock-based compensation
    
1,339
      
4,107
      
8,253
      
11,206
  
Restructuring costs
    
373
      
-
      
4,504
      
-
  
Adjusted EBITDA
  
$
(25,078
)
  
$
(24,458
)
  
$
(94,258
)
  
$
(100,568
)


 
Three months ended December 31,
    
Years ended December 31,
  

 
2023
    
2022
    
2023
    
2022
  
Total operating expenses
  
$
28,061
    
$
38,843
    
$
111,659
    
$
123,841
  
Adjustments to reconcile to Adjusted total operating expenses:
                                
Stock-based compensation
    
(1,339
)
    
(4,107
)
    
(8,253
)
    
(11,206
)
Restructuring costs
    
(373
)
    
-
      
(4,504
)
    
-
  
Goodwill impairment
    
-
      
(9,483
)
    
-
      
(9,483
)
Adjusted total operating expenses
  
$
26,349
    
$
25,253
    
$
98,902
    
$
103,152
  

Investor Contact
Jeff Keyes, Chief Financial Officer
ir@quantum-si.com

Media Contact
Katherine Atkinson, SVP, Commercial Marketing
media@quantum-si.com

Source: Quantum-Si Incorporated


 EX-99.2 3 ef20022499_ex99-2.htm EXHIBIT 99.2
Exhibit 99.2
Use of Non-GAAP Financial Measures

In addition to financial results calculated in accordance with U.S. generally accepted accounting principles (“GAAP”), information containing non-GAAP financial measures for Quantum-Si Incorporated (the “Company”) was disclosed in the Company's press release (the “Press Release”) dated February 29, 2024 announcing results for the three months and full year ended December 31, 2023, that accompany a conference call to be held by the Company on February 29, 2024.  The non-GAAP financial measures disclosed by the Company should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements should be carefully evaluated. The non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. The Company has provided reconciliations of the non-GAAP financial measures to the most directly comparable GAAP financial measures.  Management encourages readers to rely upon the reported GAAP results but includes the non-GAAP financial measures as supplemental metrics to assist readers. Definitions of the non-GAAP financial measures are included in the Press Release.

In the Press Release, the Company presented the non-GAAP financial measures “adjusted total operating expenses” and “adjusted EBTIDA."  Company management uses these non-GAAP financial measures to evaluate the Company's performance.  As the Company's core business is developing and commercializing products associated with proteomics sequencing, Company management finds it useful to use adjusted total operating expenses, which excludes goodwill impairment, stock-based compensation and restructuring costs.  While the Company may have these types of items and charges in the future, Company management believes they are not reflective of the day-to-day core operations of the Company and relate more to strategic, multi-year corporate actions, without predictable trends, and that may obscure the trends and financial performance of the Company's core business. In the case of “adjusted EBITDA,” Company management believes the exclusion of interest, taxes, depreciation, amortization, goodwill impairment, dividend income, unrealized and realized gains and losses on marketable securities, changes in fair value of warrant liabilities, and other income or expense is a very common measure utilized in the investment community and it helps Company management benchmark its operations and results with the industry.

The limitation associated with using these non-GAAP financial measures is that these measures exclude items that impact the Company's current period operating results. This limitation is best addressed by using these non-GAAP financial measures in combination with “total operating expenses” and “net loss,” (the most comparable GAAP measures) because these non-GAAP financial measures do not reflect items that impact current period operating results and may be higher or lower than the most comparable GAAP measure.


 EX-101.SCH 4 qsi-20240229.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 5 qsi-20240229_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 6 qsi-20240229_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Class of Stock [Domain] Common Class A [Member] Class of Stock [Axis] Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Entity Listings [Table] Entity Listings [Line Items] Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share [Member] EX-101.PRE 7 qsi-20240229_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 8 image00005.jpg begin 644 image00005.jpg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end XML 9 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Document and Entity Information
Feb. 29, 2024
Entity Listings [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date Feb. 29, 2024
Entity File Number 001-39486
Entity Registrant Name Quantum-Si Inc
Entity Central Index Key 0001816431
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 85-1388175
Entity Address, Address Line One 29 Business Park Drive
Entity Address, City or Town Branford
Entity Address, State or Province CT
Entity Address, Postal Zip Code 06405
City Area Code 866
Local Phone Number 688-7374
Entity Emerging Growth Company false
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Common Class A [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security Class A common stock, par value $0.0001 per share
Trading Symbol QSI
Security Exchange Name NASDAQ
Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
Trading Symbol QSIAW
Security Exchange Name NASDAQ
EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 3 22 1 false 2 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://quantum-si.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports ef20022499_8k.htm qsi-20240229.xsd qsi-20240229_def.xml qsi-20240229_lab.xml qsi-20240229_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 18 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ef20022499_8k.htm": { "nsprefix": "qsi", "nsuri": "http://quantum-si.com/20240229", "dts": { "inline": { "local": [ "ef20022499_8k.htm" ] }, "schema": { "local": [ "qsi-20240229.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "definitionLink": { "local": [ "qsi-20240229_def.xml" ] }, "labelLink": { "local": [ "qsi-20240229_lab.xml" ] }, "presentationLink": { "local": [ "qsi-20240229_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 1, "memberCustom": 1, "hidden": { "total": 5, "http://xbrl.sec.gov/dei/2023": 5 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 35, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 25 }, "report": { "R1": { "role": "http://quantum-si.com/role/DocumentAndEntityInformation", "longName": "000100 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c20240229to20240229", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20022499_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20240229to20240229", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20022499_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "us-gaap_CommonClassAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonClassAMember", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Common Class A [Member]" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityListingsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityListingsLineItems", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Listings [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityListingsTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityListingsTable", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Listings [Table]", "documentation": "Container for exchange listing information for an entity" } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "qsi_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockEachAtAnExercisePriceOf1150PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://quantum-si.com/20240229", "localname": "RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockEachAtAnExercisePriceOf1150PerShareMember", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share [Member]" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 19 0001140361-24-010435-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-24-010435-xbrl.zip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end XML 20 ef20022499_8k_htm.xml IDEA: XBRL DOCUMENT 0001816431 2024-02-29 2024-02-29 0001816431 qsi:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockEachAtAnExercisePriceOf1150PerShareMember 2024-02-29 2024-02-29 0001816431 us-gaap:CommonClassAMember 2024-02-29 2024-02-29 false Quantum-Si Inc 0001816431 NASDAQ NASDAQ 8-K 2024-02-29 DE 001-39486 85-1388175 29 Business Park Drive Branford CT 06405 866 688-7374 false false false false Class A common stock, par value $0.0001 per share QSI Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share QSIAW false